简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-10-21 15:56 HistoSonics Announces Oversubscribed $250 Million Growth Financing
2025-10-20 14:07 Iksuda Presents Encouraging IKS014 Phase 1 Data at ESMO
2025-10-20 13:26 NEL Animal Medical Foundation Brings K-Veterinary Excellence at ASASVC
2025-10-20 10:13 Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT
2025-10-17 13:54 New Roquette Pharmaceutical Innovation Center to Strengthen Latin America as Collaborative Hub
2025-10-17 11:23 Gradiant Secures $50 Million Credit Facility from HSBC, Exceeding $100 Million in Total Financing Capacity
2025-10-14 12:38 BeOne Medicines’ Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDA
2025-10-13 14:13 Pacific Prime Hong Kong Wins Top Producer for SMEs and Top Growth Driver for SMEs Awards from Bupa Global
2025-10-13 11:06 Mundipharma announces patient enrolment completion in Phase III ReSPECT clinical trial for REZZAYO® (rezafungin)
2025-10-11 15:44 Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent
2025-10-11 15:32 Tempus Joins Parse Biosciences’ Certified Service Provider Network
2025-10-11 13:19 In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones
2025-10-11 10:44 Celltrion Presents Positive Real-World Data on Switching from intravenous (IV) to subcutaneous (SC) infliximab at UEG Week 2025 Meet the Expert sessions
2025-10-10 15:52 Children's Hospital Los Angeles Recognized Among the United States' Top 10 Children's Hospitals for 17 Consecutive Years
2025-10-10 15:47 Bimiralisib, Topical PI3K/mTOR Inhibitor Shows Up To 92% Clearance Rate And Superior Tolerability In Proof-Of-Concept Actinic Keratosis Study
2025-10-10 15:41 Heidi Secures $65 Million USD in Series B Funding to Accelerate Building an AI Care Partner for Every Clinician
2025-10-10 10:59 Neuraptive Therapeutics, Inc. Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care in the Treatment of Upper Extremity Transected Nerves Requiring Surgical Repair
2025-10-10 10:19 Sobi Selects Kinaxis to Accelerate Access to Life-Changing Treatments
2025-10-09 16:22 Parse Biosciences Expands Global Access by Certifying Single Cell Discoveries as a Service Provider
2025-10-09 15:12 WHOOP Launches Clinician-Reviewed Advanced Labs, Unlocking a Comprehensive View of Human Health

Business Wire Weibo

Press Releases

Latest Releases